CEO, Medicare Advantage · CLOVER HEALTH INVESTMENTS, CORP. /DE · Class A Common Stock
Side
F
Value
$41K
Shares
14.7K
Price
$2.81
Executed
Jan 15, 2026
Disclosed
Jan 20, 2026
Disclosure timeline5 days from execution to publication · legal deadline 2 business days
Jan 15 executedJan 20, 2026 disclosed
CLOV · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Tax withholding — administrative, little informational value
Relative size+1 / 25
$41K reported value · 0.5% of prior position
Filing timing+6 / 15
Disclosed 3 business days after execution (deadline: 2)
Historical behavior+4 / 15
3 prior trades recorded in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
Pre-arranged plan-10
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Reynoso Jamie L. filed this Form 4 reporting a tax withholding of CLOV on Jan 15, 2026. It became public on Jan 20, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
CEO, Medicare Advantage
Reynoso Jamie L.cik:0001839066
Issuer
CLOVER HEALTH INVESTMENTS, CORP. /DEcik:0001801170
Revision history · 0
No field has changed since this record was first ingested.
